Company intelligence / Profile preview

Respiratory Medicine Research Institute of Michigan

Ypsilanti, Michigan, United Statesannarborallergy.com ↗

Ownership: Private
Development stage: Commercial

Overview

Respiratory Medicine Research Institute of Michigan has over two decades of experience contributing to Phase 1-3 clinical trials as a principal site, often with board-certified allergists and pulmonologists as principal investigators. It regularly participates in pivotal trials for asthma, allergy, and respiratory therapies, including biologics and investigational vaccines; some trials are industry sponsored and offer patients access to novel therapies prior to commercial availability.

Therapeutic areas: ImmunologyInfectious DiseasesPulmonology
Modalities: Small moleculeBiologicVaccineDevice
Industry: Contract Research Organization

Partnerships

DBV Technologies

Beyond the preview

Go deeper on Respiratory Medicine Research Institute of Michigan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respiratory Medicine Research Institute of Michigan.

Explore the full profile